Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Din Kørende Høreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   4.3% 7.5% 5.4% 6.4% 5.3% 4.7% 14.1% 13.9%   Credit score (0-100)   49 32 40 36 41 45 16 16   Credit rating   BBB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,835 1,961 1,452 848 1,153 829 0.0 0.0   EBITDA   208 87.0 -44.1 187 187 -80.3 0.0 0.0   EBIT   201 72.2 -71.5 160 162 -102 0.0 0.0   Pre-tax profit (PTP)   195.6 65.1 -99.1 140.3 135.4 -82.4 0.0 0.0   Net earnings   150.4 48.5 -81.0 106.9 100.8 -66.3 0.0 0.0   Pre-tax profit without non-rec. items   196 65.1 -99.1 140 135 -82.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   23.9 119 91.3 63.9 38.8 16.9 0.0 0.0   Shareholders equity total   338 387 306 413 514 447 397 397   Interest-bearing liabilities   54.6 247 267 0.0 28.8 0.0 0.0 0.0   Balance sheet total (assets)   1,019 1,970 1,483 1,049 1,044 1,019 397 397   Net Debt   -287 -506 156 -147 -193 -170 -397 -397     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,835 1,961 1,452 848 1,153 829 0.0 0.0   Gross profit growth   58.2% 6.9% -25.9% -41.6% 36.1% -28.1% -100.0% 0.0%   Employees   1 2 2 2 2 2 0 0   Employee growth %   -50.0% 100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,019 1,970 1,483 1,049 1,044 1,019 397 397   Balance sheet change%   49.8% 93.3% -24.7% -29.3% -0.4% -2.4% -61.0% 0.0%   Added value   207.6 87.0 -44.1 187.5 189.4 -80.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   8 80 -55 -55 -50 -44 -17 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.9% 3.7% -4.9% 18.9% 14.1% -12.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.6% 4.8% -4.1% 12.6% 15.5% -7.3% 0.0% 0.0%   ROI %   67.1% 14.0% -11.8% 32.4% 33.8% -15.2% 0.0% 0.0%   ROE %   57.2% 13.4% -23.4% 29.8% 21.8% -13.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   33.2% 19.6% 20.6% 39.4% 49.2% 43.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -138.3% -581.0% -353.4% -78.2% -103.4% 211.1% 0.0% 0.0%   Gearing %   16.1% 63.9% 87.3% 0.0% 5.6% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.6% 4.7% 10.8% 14.8% 185.2% 51.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.4 1.0 1.0 1.4 1.8 1.6 0.0 0.0   Current Ratio   1.4 1.1 1.1 1.5 1.8 1.7 0.0 0.0   Cash and cash equivalent   341.7 752.8 111.0 146.7 222.3 169.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   300.7 221.4 163.4 300.1 423.5 379.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   208 44 -22 94 95 -40 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   208 44 -22 94 94 -40 0 0   EBIT / employee   201 36 -36 80 81 -51 0 0   Net earnings / employee   150 24 -40 53 50 -33 0 0